98%
921
2 minutes
20
Recently, 5-[(4-ethoxyphenyl)imino]methyl-N-(4-fluorophenyl)-6-methyl-2-phenylpyrimidin-4-amine has been synthesized, characterized, and evaluated for its antibacterial activity against in combination with antineoplastic activity against gastric adenocarcinoma. In this study, new 5-iminomethylpyrimidine compounds were synthesized which differ in the substituent(s) of the aromatic ring attached to the imine group. The structures of newly obtained pyrimidine Schiff bases were established by spectroscopy techniques (ESI-MS, FTIR and H NMR). To extend the current knowledge about the features responsible for the biological activity of the new 5-iminomethylpyrimidine derivatives, low-temperature single-crystal X-ray analyses were carried out. For all studied crystals, intramolecular N-H∙∙∙N hydrogen bonds and intermolecular C-H∙∙∙F interactions were observed and seemed to play an essential role in the formation of the structures. Simultaneously, their biological properties based on their cytotoxic features were compared with the activities of the Schiff base (III) published previously. Moreover, computational investigations, such as ADME prediction analysis and molecular docking, were also performed on the most active new Schiff base (compound ). These results were compared with the highest active compound .
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10889512 | PMC |
http://dx.doi.org/10.3390/ijms25042076 | DOI Listing |
RSC Adv
June 2025
Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences Chennai-600077 Tamil Nadu India
A sustainable and efficient microwave-assisted strategy was developed for the synthesis of novel 4-amino-pyrrolo [2,3-]pyrimidine-based Schiff base derivatives (APR1a-d), utilizing the ionic liquid 1-hexyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide ([HMIM][TFSI]) as both catalyst and solvent. This green protocol afforded high yields (82-94%) under mild conditions with excellent reusability of the ionic liquid. Structural confirmation was achieved FT-IR, H and C NMR, and mass spectrometry.
View Article and Find Full Text PDFACS Biomater Sci Eng
July 2025
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Minoxidil is the only FDA approved topical treatment for androgenetic alopecia, which is male- or female-pattern hair loss. However, its use is limited by its efficacy and tolerability. Here, we describe a novel bioengineered approach to improve local delivery to the skin.
View Article and Find Full Text PDFInt J Biol Macromol
June 2025
Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals & Ministry-of-Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei University, Wuhan 430062, China. Electronic address:
Current research on antibacterial hydrogel dressings remains predominantly focused on bacterial pathogen management, while facing technical bottlenecks in constructing synergistic antifungal therapeutic systems. The limitations of this narrow antimicrobial spectrum pose significant clinical challenges, particularly pronounced in burn wound management characterized by pathological healing microenvironments. Notably, existing biomaterials exhibit dual deficiencies when addressing polymicrobial infections: neither capable of mitigating antibiotic resistance risks nor equipped with active tissue regeneration modulation capabilities.
View Article and Find Full Text PDFNanoscale Horiz
June 2025
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, India.
Combination chemotherapy using nanocarriers presents a promising approach to overcome the restrictions associated with conventional chemotherapy, particularly by enhancing drug stability in the bloodstream, modulating pharmacokinetics to improve therapeutic efficacy and minimizing adverse side effects on the patient's health. In pursuit of an optical treatment approach for breast cancer, various chemotherapeutic drug combinations with advanced nanocarriers are being extensively explored. This study investigated the development of pirarubicin and gemcitabine co-loaded polymeric nanoparticles for synergistic activity against breast cancer cells.
View Article and Find Full Text PDFEur J Med Chem
September 2025
Applied Organic Chemistry Department, National Research Center, Dokki, 12622, Cairo, Egypt. Electronic address:
Developing novel anticancer agents that target critical pathways in non-small cell lung cancer (NSCLC) presents a considerable challenge. This study synthesized 16 pyrazolo[1,5-a]pyrimidine derivatives with zinc-binding groups through molecular hybridization to achieve dual-target inhibition of tumor-associated carbonic anhydrase (CA) isoforms IX/XII and cyclin-dependent kinase 6 (CDK6). In-vitro assays indicated that sulfonamide-bearing compounds displayed enhanced CA inhibition, with compounds 7d, 11b, and 11d presenting K values of 11.
View Article and Find Full Text PDF